Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography

The diagnostic value of <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake in the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas remains unclear. This study aimed to assess the role of FDG uptake in the diagnosis of different degrees of dysplasia of IPMNs. We...

Full description

Bibliographic Details
Main Authors: Yuto Hozaka, Hiroshi Kurahara, Hideyuki Oi, Tetsuya Idichi, Yoichi Yamasaki, Yota Kawasaki, Kiyonori Tanoue, Megumi Jinguji, Masatoyo Nakajo, Atsushi Tani, Akihiro Nakajo, Yuko Mataki, Yoshihiko Fukukura, Hirotsugu Noguchi, Michiyo Higashi, Takashi Yoshiura, Akihide Tanimoto, Takao Ohtsuka
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
FDG
PET
Online Access:https://www.mdpi.com/2072-6694/13/18/4633
id doaj-e30e2b1a5e3f44fb8efe7ec412d21d0e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yuto Hozaka
Hiroshi Kurahara
Hideyuki Oi
Tetsuya Idichi
Yoichi Yamasaki
Yota Kawasaki
Kiyonori Tanoue
Megumi Jinguji
Masatoyo Nakajo
Atsushi Tani
Akihiro Nakajo
Yuko Mataki
Yoshihiko Fukukura
Hirotsugu Noguchi
Michiyo Higashi
Takashi Yoshiura
Akihide Tanimoto
Takao Ohtsuka
spellingShingle Yuto Hozaka
Hiroshi Kurahara
Hideyuki Oi
Tetsuya Idichi
Yoichi Yamasaki
Yota Kawasaki
Kiyonori Tanoue
Megumi Jinguji
Masatoyo Nakajo
Atsushi Tani
Akihiro Nakajo
Yuko Mataki
Yoshihiko Fukukura
Hirotsugu Noguchi
Michiyo Higashi
Takashi Yoshiura
Akihide Tanimoto
Takao Ohtsuka
Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
Cancers
IPMN
FDG
PET
mural nodule
high-grade dysplasia
glucose transporter 1
author_facet Yuto Hozaka
Hiroshi Kurahara
Hideyuki Oi
Tetsuya Idichi
Yoichi Yamasaki
Yota Kawasaki
Kiyonori Tanoue
Megumi Jinguji
Masatoyo Nakajo
Atsushi Tani
Akihiro Nakajo
Yuko Mataki
Yoshihiko Fukukura
Hirotsugu Noguchi
Michiyo Higashi
Takashi Yoshiura
Akihide Tanimoto
Takao Ohtsuka
author_sort Yuto Hozaka
title Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
title_short Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
title_full Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
title_fullStr Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
title_full_unstemmed Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
title_sort clinical utility and limitation of diagnostic ability for different degrees of dysplasia of intraductal papillary mucinous neoplasms of the pancreas using <sup>18</sup>f-fluorodeoxyglucose-positron emission tomography/computed tomography
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2021-09-01
description The diagnostic value of <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake in the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas remains unclear. This study aimed to assess the role of FDG uptake in the diagnosis of different degrees of dysplasia of IPMNs. We retrospectively analyzed the following three points in 84 patients with IPMNs: (1) risk factors to predict high-grade dysplasia (HGD) and invasive carcinoma (INV); (2) the relationship between FDG uptake and glucose transporter 1 (GLUT-1) expression; and (3) the relationship between FDG uptake and the presence of mural nodules. The histopathological diagnosis was low-grade dysplasia (LGD) in 43 patients, HGD in 16, and INV in 25. The maximum standardized uptake value (SUV-max) was significantly higher in INV than in LGD/HGD (<i>p</i> < 0.0001, <i>p</i> = 0.0136). The sensitivity and specificity to discriminate INV from LGD/HGD were 80.0% and 86.2%, respectively, using the receiver operator characteristic curve, when the optimal cutoff score of SUV-max was set at 4.03. Those values were not different between HGD and LGD. More than half of HGD patients had low GLUT-1 expression. Taken together, FDG-PET/CT is useful in distinguishing between non-invasive and invasive IPMN. Our results offer critical information that may determine surgical treatment strategies.
topic IPMN
FDG
PET
mural nodule
high-grade dysplasia
glucose transporter 1
url https://www.mdpi.com/2072-6694/13/18/4633
work_keys_str_mv AT yutohozaka clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT hiroshikurahara clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT hideyukioi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT tetsuyaidichi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT yoichiyamasaki clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT yotakawasaki clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT kiyonoritanoue clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT megumijinguji clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT masatoyonakajo clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT atsushitani clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT akihironakajo clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT yukomataki clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT yoshihikofukukura clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT hirotsugunoguchi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT michiyohigashi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT takashiyoshiura clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT akihidetanimoto clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT takaoohtsuka clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography
_version_ 1717367886921596928
spelling doaj-e30e2b1a5e3f44fb8efe7ec412d21d0e2021-09-25T23:49:44ZengMDPI AGCancers2072-66942021-09-01134633463310.3390/cancers13184633Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed TomographyYuto Hozaka0Hiroshi Kurahara1Hideyuki Oi2Tetsuya Idichi3Yoichi Yamasaki4Yota Kawasaki5Kiyonori Tanoue6Megumi Jinguji7Masatoyo Nakajo8Atsushi Tani9Akihiro Nakajo10Yuko Mataki11Yoshihiko Fukukura12Hirotsugu Noguchi13Michiyo Higashi14Takashi Yoshiura15Akihide Tanimoto16Takao Ohtsuka17Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanThe diagnostic value of <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake in the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas remains unclear. This study aimed to assess the role of FDG uptake in the diagnosis of different degrees of dysplasia of IPMNs. We retrospectively analyzed the following three points in 84 patients with IPMNs: (1) risk factors to predict high-grade dysplasia (HGD) and invasive carcinoma (INV); (2) the relationship between FDG uptake and glucose transporter 1 (GLUT-1) expression; and (3) the relationship between FDG uptake and the presence of mural nodules. The histopathological diagnosis was low-grade dysplasia (LGD) in 43 patients, HGD in 16, and INV in 25. The maximum standardized uptake value (SUV-max) was significantly higher in INV than in LGD/HGD (<i>p</i> < 0.0001, <i>p</i> = 0.0136). The sensitivity and specificity to discriminate INV from LGD/HGD were 80.0% and 86.2%, respectively, using the receiver operator characteristic curve, when the optimal cutoff score of SUV-max was set at 4.03. Those values were not different between HGD and LGD. More than half of HGD patients had low GLUT-1 expression. Taken together, FDG-PET/CT is useful in distinguishing between non-invasive and invasive IPMN. Our results offer critical information that may determine surgical treatment strategies.https://www.mdpi.com/2072-6694/13/18/4633IPMNFDGPETmural nodulehigh-grade dysplasiaglucose transporter 1